SCHEMBL2786644

SCHEMBL2786644

Cc1cc(CC(=O)O)cc(Br)c1Oc1ccc(O)c(Oc2ccccc2)c1

nearest known ligand 0.85

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
THRB P10828 19/20 0.85
THRA P10827 17/20 0.85
NR3C1 P04150 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2786623 0.92 THRB (1.00) THRBTHRA
SCHEMBL2787262 0.87 THRB (0.82) THRBTHRA
SCHEMBL2786463 0.86 THRB (0.89) THRBTHRA
SCHEMBL2788880 0.85 THRB (1.00) THRBTHRA
SCHEMBL2788927 0.84 THRB (1.00) THRBTHRA
SCHEMBL2786835 0.84 THRB (1.00) THRBTHRA
SCHEMBL2786871 0.84 THRB (0.84) THRBTHRA
SCHEMBL2788697 0.84 THRB (1.00) THRBTHRA
SCHEMBL2786910 0.83 THRB (0.82) THRBTHRA
SCHEMBL2786567 0.83 THRB (0.82) THRBTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7557143-B2 Thyroid receptor ligands BRISTOL-MYERS SQUIBB COMPANY (US) 2009-07-07 US claimed
US-8263659-B2 Thyroid receptor ligands BRISTOL-MYERS SQUIBB COMPANY (US) 2012-09-11 US disclosed
US-20100298276-A1 THYROID RECEPTOR LIGANDS BRISTOL-MYERS SQUIBB COMPANY 2010-11-25 US disclosed
US-7557143-B2 Thyroid receptor ligands BRISTOL-MYERS SQUIBB COMPANY (US) 2009-07-07 US disclosed
US-20050004184-A1 Thyroid receptor ligands BRISTOL-MYERS SQUIBB COMPANY 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298276-A1 THYROID RECEPTOR LIGANDS TSHR, THRA, THRB THRB 3/4885THRA 2/4885NR3C1 51/4885
US-20050004184-A1 Thyroid receptor ligands TSHR, THRA, THRB THRB 3/4885THRA 2/4885NR3C1 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.